Nachdem man elf Jahre in-vitroforschung, Sicherheit und Giftigkeitstudien und klinische Versuche, im August von 2006 durchgeführt hatte, wurde die CKD Grundlage von W.Jean und von James Herman gegründet um Alphamir™ in den Handel zu bringen und zahlreich andere Trioxolane Ableitungen. Die CKD Foundation hält die eigenen Rechte zu einigen Patenten in Bezug auf Oxydationtechnologien und verwendet, einschließlich das Patent für den Schlüsselbestandteil in seinen ethischen Medikamenten, das medizinische Mittel Trioxolane. Seit der Gründung, lizensiert die CKD Foundation, die alle Rechte hält, ausschließlich BIOCHEM Solutions Inc., um alle Marketing-, Verkaufs-, Verteilungs- und Produktionsdisziplinen durchzuführen. Die Firma hat eine Labor- und Produktionsanlage, die groß genug ist, den Anforderungen einer erhöhten Produktionskapazität zu entsprechen.
Die Firma hat zusätzlich eine Niederlassung in Nassau, Bahamas instaliert, um der erwarteten Nachfrage nachzukommen.

W. Jean Herman, as Chairman of BIOCHEM SOLUTIONS INC., is responsible for providing the overall vision for the Company and to identify and lead research into innovative formulations for the treatment of bacterial, viral, and fungal diseases that have widespread, volume market potential. She also is to provide leadership in designing research studies to conduct clinical trials using FDA accepted protocols.

Mr. James Herman received his BS in Chemistry from the University of California at Irvine, California, in 1982. Since then Mr. Herman has held positions with Parker Hannifin Corporation, performing chemical analysis to diagnose hydraulic servo failure on Fa18 aircraft, Sikorsky Blackhawk’s, and Space Shuttle landing gear. He assisted in developing nonflammable hydraulic fluids for military applications. His next position was with the Laser Precision Corporation as a senior research and development chemist. His primary objectives were to design hyphenated analytical instrumentation used in forensic analysis. From this experience he was requested to assist and instruct the F.B.I. and the D.E.A. at the F.B.I academy in Quantico, Virginia.

BUSINESS EXPERIENCE

V.P. Finance & Administration Innovative Stone Corp.
C.F.O. Global Access Communications Inc.
C.F.O. & Secretary National Electronic Technologies Corp.
C.F.O. & Director IBI Corp.
Professor/Part-time Instructor George Brown College Seneca College of Applied Arts & Technology
Georgian College (1991-present)
President Jensen Financial Consultants (1990-present)
Vice-President & Treasurer The Imperial Life Assurance Co. of Canada (1989-1990)
Senior Manager, Capital Markets Bank of Nova Scotia (1987-1989)
Vice-President, First National Bank of Chicago (Canada)
International Capital Markets .(1986-1987) Treasurer Ralston Purina Canada Inc. (1984-1986) EDUCATION

M.Sc. Financial Economics- in progress University of London
FCSI (Fellow of the Canadian Securities Institute) Canadian Securities Institute
CFA (Chartered Financial Analyst)-in progress AIMR
FMA (Financial Management Advisor)Canadian Securities Institute
U.S. Futures & Options Course NASD
French – conversational Berlitz
B. A., Economics York University
B. Sc., Cellular & Microbial Biology University of Calgary
Professional Affiliations
Member of the Association of Investment Management Research AIMR

BSc, MS, PhD, CuD, DSc, CBiol, FIBiol, FInstPM, SS, OGW, MBS Chief Research Officer, Director & Chief Executive: Kenya Medical Research Institute (KEMRI) Professor of Immunology & Molecular Medicine

DAVY KIPROTICH KOECH (born 1951) is a founder member, Chief Research Officer, Director and Chief Executive, Kenya Medical Research Institute (KEMRI), a state-owned organization charged with the responsibility of carrying out health sciences research in Kenya. He has been a member (1985-90), the Vice-Chairman (1990-95) and the Chairman (1995-2003) of the Commission for Higher Education; and the Vice-Chairman (1993-2003) of Council of the Jomo Kenyatta University of Agriculture and Technology, Kenya. In addition, he is a visiting professor of Immunology and Molecular Medicine (1989-date) in a number of universities. Also, Dr. Koech was the Chairman of the Commission of Inquiry into the Education System of Kenya (1998-1999), that came up with a report titled Totally Integrated Quality Education and Training (TIQET) recommending major changes in Kenya’s education system. Education, Research and Professional Interests

Dr. Koech holds three doctorates: Doctor of Science (DSc) from Moi University, and Cultural Doctorate (CuD) in Therapeutic Philosophy (1988) from the World University in the USA; a PhD degree in Medical Pathology (1980) specializing in immunology awarded by the University of Nairobi but partly undertaken at the Harvard University Medical School, Boston, Massachusetts, USA while he was a Fulbright-Hays Scholar; an MS degree in Pharmacology (1977) specializing in Clinical Pharmacology from Duquesne University in Pittsburgh, Pennsylvania, USA and a BSc degree (1974) obtained from the University of Nairobi. Dr. Koech is also a Chartered Biologist (CBiol) (1984), a member (MIBiol)(1984-96) and a Fellow of the Institute of Biology (FIBiol) (1997-date) of the UK, and a Fellow of the Institute of Professional Managers (FInstPM) (1985-date) of Great Britain. In addition, he is a member of several professional societies including the Kenya Society of Clinical Pathologists, the Kenya Society for Immunology, the British Society for Immunology, the British Transplantation Society, the Royal Society of Medicine and the American Association for the Advancement of Science.

Park House, Tongland, Kirkcudbright, DG6 4NE, United Kingdom
Educated at Kirkcudbright Academy. George Watsons College, Edinburgh.
Lincoln Agricultural College, New Zealand.
Conservative Member of the European Parliament for Worcestershire and South Warwickshire, 1994 - 1999.
West Midlands Region 1999-
Elected Honorary Life President ACP/EU Joint Parliamentary Assembly 2002
European President ACP/EU Joint Parliamentary Assembly 1999-2002.
Honorary Life President ACP/EU. Vice-President ACP/EU 2002-
Co-ordinator of the Development Committee EPP/ED Group 1999-
Committees - Development Committee, Budgets Committee, Member of the African, Caribbean and Pacific Joint Parliamentary Assembly, and Rapporteur for LOME IV Mid-Term Review.
Rapporteur for Regional Co-operation.
Chairman of the Backbench (1979) Committee of the Conservatives in Europe 1995-97.
Chief Whip of the British Section 1997-1999
Conservative Member of Parliament- Bute and North Ayrshire 1974-1983.
Cunninghame North 1983-1987.
Member of the European Assembly 1975-1976, and from 1977-1979. Served on Regional , Transport,
Agricultural and External Affairs Committees. Vice-Chairman EEC Turkish Committee.
Nominated to Council of Europe 1983-1987. Conservative Whip.
Agricultural, Regional Planning and Migration Committees.
Nominated to Western European Union (Defence) 1983-1987.
At Westminster served as Opposition Whip., Education Spokesman, Chairman Conservative Backbench Group, Chairman of Scottish Select Committee, Parliamentary Private Secretary to Secretary of State for Scotland.
Introduced Private Members Bill to reduce upper time limit on abortion (1979). Awarded Wilberforce Plaque for Humane Work 1981.
Enacted “Diseases of Fish” Bill as Private Members Bill ,1981.
Author of “Forestry in Europe” “Fish Farming in Europe” “The Importance of Forestry in the World Today”. Co-Author with Sir James Scott-Hopkins of “Towards a Community Rural Policy”.
Chairman Transport Users Consultative Committee Scotland. Vice-Chairman of the Central Transport
Consultative Committee in London (1988-1994)
Family farm in Galloway, and has farmed in New Zealand. Nuffield Farming Scholar 1972.
Council Member Royal Agricultural Society of England, NAC, Warwickshire. 1991- 2000
Senior Instructor British Wool Board, Agricultural Training Board 1970-1974.
Honorary Director of European Human Rights Group 1995-99.
Honorary Director of European Bureau for Conservation and the Environment 1995-99.
Rotarian. District Community Service Chairman 1970-1973.
Commissioned from the ranks of the New Zealand Army.
Industrial Fellowship with Conoco and Du Pont, USA. 1987.
BioChem Solutions is highly dependent upon the principal members of its management and technological staff; the ability to attract additional support staff, the loss of whose services might impede product launches and/or the attainment of strategic objectives. The Company’s success will depend on its ability to obtain proper funding needed to launch the distribution of it’s treatments to Africa and to stay ahead of the competition.

The Company has plans for several more patent applications. There is no assurance that patents will be granted, or if granted, that they will afford any meaningful protection.